Joep H G Scholl (Joep Scholl)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Loop Mediated Isothermal Amplification

Rheumatoid Arthritis Patients

Cervical Cancer Screening

Top Venues

Expert opinion on drug safety

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Kimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, Joep H G Scholl, Jurriaan R G Jansen, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept. Expert opinion on drug safety (2023)
Moa Gustafsson, Cristiano Matos, João Joaquim, Joep H G Scholl, Florence P A M van Hunsel
Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database. Drug safety (2023)
Kimberly Velthuis, Naomi T Jessurun, Thi D M Nguyen, Joep H G Scholl, Jurriaan R G Jansen, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept. Expert opinion on drug safety (2023)
Ingrid Oosterhuis, Joep H G Scholl, Eugene P van Puijenbroek, Agnes C Kant, Florence P A M van Hunsel
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience. Drug safety (2022)
Carolina Valeiro, Cristiano Matos, Joep H G Scholl, Florence P A M van Hunsel
Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database. Drug safety 45 (6) (2022)
Joep H G Scholl, Florence P A M van Hunsel, Eelko Hak, Eugene P van Puijenbroek
Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions. Pharmacoepidemiology and drug safety 28 (10) (2019)
Corine Ekhart, Florence P A M van Hunsel, Joep H G Scholl, Sieta T de Vries, Eugene P van Puijenbroek
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. Drug safety 41 (7) (2018)
Joep H G Scholl, Florence P A M van Hunsel, Eelko Hak, Eugene P van Puijenbroek
A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands. Pharmacoepidemiology and drug safety 27 (2) (2017)